EFFECT OF BLOCKING ANGIOTENSIN-II RECEPTOR SUBTYPE ON RAT SYMPATHETIC-NERVE FUNCTION

被引:76
作者
WONG, PC
BERNARD, R
TIMMERMANS, PBMWM
机构
[1] The Du Pont Merck Pharmaceutical Company, Wilmington, DE
关键词
ANGIOTENSIN RECEPTORS; ANTIHYPERTENSIVE THERAPY; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;
D O I
10.1161/01.HYP.19.6.663
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
This study examined effects of nonpeptide angiotensin II (Ang II) receptor subtype antagonists on the interaction of sympathetic function and Ang II in pithed rats. Effects of spinal cord stimulation (0.5-4 Hz) and norepinephrine (0.3-3-mu-g/kg i.v.) on mean arterial pressure (recorded with a carotid arterial catheter), cardiac output (measured with an electromagnetic flowmeter and flow probe around the thoracic ascending aorta), total peripheral resistance, and heart rate were determined. The subtype 1-selective Ang II receptor antagonist losartan (previously known as DuP 753) at 10 mg/kg i.v. blocked the hemodynamic responses to Ang II at 1-mu-g/kg i.v. It inhibited mean arterial pressure and total peripheral resistance responses but not cardiac output and heart rate responses to spinal cord stimulation. In contrast, it reduced mean arterial pressure and cardiac output responses but not total peripheral resistance and heart rate responses to intravenous norepinephrine. Given at 100 mg/kg i.v., the subtype 2-selective receptor antagonist PD123177 did not reduce hemodynamic responses to intravenous Ang II, spinal cord stimulation, and intravenous norepinephrine. These results suggest that endogenous Ang II facilitates the release of norepinephrine from sympathetic nerve terminals in the vasculature of pithed rats. Similar to the Ang II receptor in vascular smooth muscle, the prejunctional Ang II receptor in pithed rats appears to be of subtype 1.
引用
收藏
页码:663 / 667
页数:5
相关论文
共 18 条
  • [1] ANTONACCIO MJ, 1981, HYPERTENSION, V3, P54
  • [2] IDENTIFICATION AND CHARACTERIZATION OF GUINEA-PIG ANGIOTENSIN-II VENTRICULAR AND ATRIAL RECEPTORS - COUPLING TO INOSITOL PHOSPHATE PRODUCTION
    BAKER, KM
    SINGER, HA
    [J]. CIRCULATION RESEARCH, 1988, 62 (05) : 896 - 904
  • [3] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL SERIES OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR-BINDING INHIBITORS SPECIFIC FOR THE AT2 SUBTYPE
    BLANKLEY, CJ
    HODGES, JC
    KLUTCHKO, SR
    HIMMELSBACH, RJ
    CHUCHOLOWSKI, A
    CONNOLLY, CJ
    NEERGAARD, SJ
    VANNIEUWENHZE, MS
    SEBASTIAN, A
    QUIN, J
    ESSENBURG, AD
    COHEN, DM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (11) : 3248 - 3260
  • [4] NOMENCLATURE FOR ANGIOTENSIN RECEPTORS - A REPORT OF THE NOMENCLATURE-COMMITTEE OF THE COUNCIL-FOR-HIGH-BLOOD-PRESSURE-RESEARCH
    BUMPUS, FM
    CATT, KJ
    CHIU, AT
    DEGASPARO, M
    GOODFRIEND, T
    HUSAIN, A
    PEACH, MJ
    TAYLOR, DG
    TIMMERMANS, PBMWM
    [J]. HYPERTENSION, 1991, 17 (05) : 720 - 721
  • [5] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - THE DISCOVERY OF A SERIES OF N-(BIPHENYLYLMETHYL)IMIDAZOLES AS POTENT, ORALLY ACTIVE ANTIHYPERTENSIVES
    CARINI, DJ
    DUNCIA, JV
    ALDRICH, PE
    CHIU, AT
    JOHNSON, AL
    PIERCE, ME
    PRICE, WA
    SANTELLA, JB
    WELLS, GJ
    WEXLER, RR
    WONG, PC
    YOO, SE
    TIMMERMANS, PBMWM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) : 2525 - 2547
  • [6] CODY RP, 1987, APPLIED STATISTICS S
  • [7] DUDLEY DT, 1990, MOL PHARMACOL, V38, P370
  • [8] GREENWAY CV, 1982, PHARMACOL REV, V33, P213
  • [9] IMPORTANCE OF ENDOGENOUS ANGIOTENSIN-II IN THE CARDIOVASCULAR-RESPONSES TO SYMPATHETIC-STIMULATION IN CONSCIOUS RABBITS
    ISAACSON, JS
    REID, IA
    [J]. CIRCULATION RESEARCH, 1990, 66 (03) : 662 - 671
  • [10] KAUFMAN LJ, 1985, J PHARMACOL EXP THER, V235, P128